SCHEMBL1396338

SCHEMBL1396338

Cc1ccc(-n2nc3c4cc(Br)ccc4[nH]c(=O)n3c2=O)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.71
GABRG2 P18507 4/20 0.71
GABRB3 P28472 4/20 0.71
GABRA3 P34903 4/20 0.71
GABRA2 P47869 4/20 0.71
GABRA5 P31644 3/20 0.67
HAVCR2 Q8TDQ0 1/20 0.53
ADORA3 P0DMS8 6/20 0.48
JAK2 O60674 1/20 0.43
PAK4 O96013 1/20 0.43
NTRK1 P04629 1/20 0.43
LCK P06239 1/20 0.43
FYN P06241 1/20 0.43
CSF1R P07333 1/20 0.43
RET P07949 1/20 0.43
MET P08581 1/20 0.43
PDGFRB P09619 1/20 0.43
PIM1 P11309 1/20 0.43
FGFR1 P11362 1/20 0.43
PRKACA P17612 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1396379 0.88 GABRA1 (0.58) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL1396321 0.88 GABRA1 (0.74) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL1590687 0.83 GABRA1 (1.00) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL7386468 0.83 GABRA1 (0.73) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL1591552 0.80 GABRA1 (0.85) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL1396413 0.80 GABRA1 (1.00) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL1591441 0.80 GABRA1 (0.72) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL1396273 0.79 GABRA1 (0.62) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL1396324 0.79 GABRA1 (0.83) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL4237025 0.79 GABRA1 (0.64) GABRA1GABRG2GABRB3GABRA3GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2288612-B1 GABAA RECEPTOR MODULATORS GABATHER AB (SE) 2015-07-29 EP claimed
US-8809355-B2 GABAA receptor modulators INNOVATIONSPATENT SVERIGE AB (SE) 2014-08-19 US claimed
US-20110092525-A1 GABAA RECEPTOR MODULATORS GABATHER AB (SE) 2011-04-21 US claimed
EP-2288612-A1 GABAA RECEPTOR MODULATORS Forskarpatent i Syd AB (SE) 2011-03-02 EP claimed
WO-2009123537-A1 GABAa RECEPTOR MODULATORS FORSKARPATENT I SYD AB (SE) 2009-10-08 WO claimed
EP-2288612-B1 GABAA RECEPTOR MODULATORS GABATHER AB (SE) 2015-07-29 EP disclosed
US-8809355-B2 GABAA receptor modulators INNOVATIONSPATENT SVERIGE AB (SE) 2014-08-19 US disclosed
US-20110092525-A1 GABAA RECEPTOR MODULATORS GABATHER AB (SE) 2011-04-21 US disclosed
EP-2288612-A1 GABAA RECEPTOR MODULATORS Forskarpatent i Syd AB (SE) 2011-03-02 EP disclosed
WO-2009123537-A1 GABAa RECEPTOR MODULATORS FORSKARPATENT I SYD AB (SE) 2009-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092525-A1 GABAA RECEPTOR MODULATORS GABRA5, GABRA1, GABRA2 GABRA1 2/4885GABRG2 13/4885GABRB3 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.